B
Bullisch
Bullisch · 25%QSI
$4.58
Szenariopreis
$1.120
-0.162 (-14.50%)Zum Schluss
Loading chart…
- Hoch
- 1.330
- Eröffnung
- 1.330
- Volumengewichteter Durchschnittskurs
- 1.18
- Volumen
- 7.69M
- Marktkap.
- 133.31M
- Tief
- 1.100
- Umsatz
- 9.10M
- EV/EBITDA, TTM
- -0.62
Quantum-SI Incorporated is a life sciences company. The Company has designed and developed a hardware, consumable and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins. Its launched product consists of Platinum, the Platinum Analysis Software and consumables. Its flagship protein sequencing instrument, Platinum, is designed to make the power of single-molecule detection and NGPS accessible. Platinum is designed to provide a streamlined workflow compared to legacy MS workflows. Platinum uses its proprietary semiconductor chip that leverages time-domain sequencing with an initial focus on NGPS for an unbiased view of the proteome.
KI-Analyse of Quantum-Si Inc (QSI)
VerkaufenQuantum-Si Inc. is not a good buy right now. The current price is $1.12, and the stock has a 1-year change of -56.67%, indicating severe underperformance. Additionally, the RSI is at 38.07, suggesting it is nearing oversold territory but has not yet shown signs of recovery. The main risk is the high insider selling, which has increased by 336.04% over the last month, indicating a lack of confidence from those closest to the company.
Bewertungskennzahlen
Das aktuelle erwartete KGV von Quantum-Si Inc (QSI) beträgt 0.00, verglichen mit dem 5-Jahres-Durchschnitt von -3.21.
Alphio-AI-Kursszenarien für QSI
Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.
Event-Zeitleiste
News
9.508-20NASDAQ.COMQuantum-Si Reports Q2 2026 Financial Results and Proteus Development Update
5.005-14NewsfilterQuantum-Si Grants Restricted Stock Units to New Employees
9.505-08seekingalphaQuantum-Si Q1 2026 Earnings Call Insights
- 1.005-01Newsfilter
Quantum-Si to Participate in H.C. Wainwright BioConnect Investor Conference
- 3.504-28Newsfilter
Quantum-Si Achieves Milestone in Protein Sequencing with Proteus Instruments
QSI FAQ – beantwortet von Alphio AI
Quantum-SI Incorporated is a life sciences company. The Company has designed and developed a hardware, consumable and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins. Its launched product consists of Platinum, the Platinum Analysis Software and consumables. Its flagship protein sequencing instrument, Platinum, is designed to make the power of single-molecule detection and NGPS accessible. Platinum is designed to provide a streamlined workflow compared to legacy MS workflows. Platinum uses its proprietary semiconductor chip that leverages time-domain sequencing with an initial focus on NGPS for an unbiased view of the proteome. It operates in the Healthcare sector (MEASURING & CONTROLLING DEVICES, NEC industry).
Quantum-Si Inc. is not a good buy right now. The current price is $1.12, and the stock has a 1-year change of -56.67%, indicating severe underperformance. Additionally, the RSI is at 38.07, suggesting it is nearing oversold territory but has not yet shown signs of recovery. The main risk is the high insider selling, which has increased by 336.04% over the last month, indicating a lack of confidence from those closest to the company.
Community
Mehr ↗
Wall St is expecting -0.12 EPS for $QSI Q3 [Reporting 11/11 AMC]
Mehr anzeigenDiese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.